Christopher Ellis - Aug 17, 2022 Form 4 Insider Report for Vaccitech plc (VACC)

Signature
/s/ William Enright, Attorney-in-Fact
Stock symbol
VACC
Transactions as of
Aug 17, 2022
Transactions value $
-$13,623
Form type
4
Date filed
8/19/2022, 04:06 PM
Previous filing
Aug 17, 2022
Next filing
Aug 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VACC Ordinary Shares Options Exercise $0.26 +649 +865.33% $0.00* 724 Aug 17, 2022 Direct F1
transaction VACC Ordinary Shares Sale -$3.09K -649 -89.64% $4.77 75 Aug 17, 2022 Direct F1, F2
transaction VACC Ordinary Shares Options Exercise $0.87 +2.18K +2900% $0.00* 2.25K Aug 18, 2022 Direct F1
transaction VACC Ordinary Shares Sale -$10.5K -2.18K -96.67% $4.84 75 Aug 18, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VACC Share Option (Right to Buy) Options Exercise $0 -649 -1.49% $0.00 42.8K Aug 17, 2022 Ordinary Shares 649 $0.00 Direct F1, F4
transaction VACC Share Option (Right to Buy) Options Exercise $0 -2.18K -5.08% $0.00 40.6K Aug 18, 2022 Ordinary Shares 2.18K $0.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 - $4.80. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.18 - $4.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.